1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. NovoCure Limited
  6. Consensus
    NVCR   JE00BYSS4X48

NOVOCURE LIMITED

(NVCR)
  Report
Delayed Nasdaq  -  04:00 2022-08-11 pm EDT
82.54 USD   +3.32%
08/10Novocure Hosts U.S. Sen. Maggie Hassan at Company's Portsmouth Facility
BU
08/04INSIDER SELL : Novocure
MT
07/29Truist Securities Drops NovoCure's Price Target to $105 From $118, Keeps Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on NOVOCURE LIMITED
Target Price consensus revisions : last 18 months
Recommendations (Chart) NOVOCURE LIMITED
Analyst Recommendations on NOVOCURE LIMITED
07/29Truist Securities Drops NovoCure's Price Target to $105 From $118, Keeps Buy Rating
MT
07/29Piper Sandler Adjusts NovoCure's Price Target to $90 From $100, Reiterates Overweight Rati..
MT
07/05Evercore ISI Downgrades NovoCure to Underperform From In-Line
MT
06/06HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
05/16HC Wainwright Initiates NovoCure at Buy With $115 Price Target
MT
05/13Piper Sandler Adjusts NovoCure's Price Target to $100 From $125, Reiterates Overweight Rat..
MT
04/04Evercore ISI Adjusts Price Target for NovoCure to $82 From $62, Maintains In-Line Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 82,54 $
Average target price 94,25 $
Spread / Average Target 14,2%
High Price Target 200,00 $
Spread / Highest target 142%
Low Price Target 45,00 $
Spread / Lowest Target -45,5%
Consensus detail
Consensus revision (last 18 months)